albumina umana grifols 200g/l
instituto grifols s.a. - spania - albuminum umane - sol. perf. - 200g/l - sange si substituenti de sange substituenti de sange si fractiuni proteice plasmatice
albutein 200 g/l
instituto grifols s.a. - spania - albuminum umane - sol. perf. - 200g/l - sange si substituenti de sange substituenti de sange si fractiuni proteice plasmatice
albutein 50 g/l
instituto grifols s.a. - spania - albuminum umane - sol. perf. - 50g/l - sange si substituenti de sange substituenti de sange si fractiuni proteice plasmatice
fanhdi 250 ui
instituto grifols s.a. - spania - factorul viii de coagulare - pulb.+solv. pt. sol. inj. - 250ui - vitamina k si alte hemostatice factori ai coagularii sanguine
fanhdi 500 ui
instituto grifols s.a. - spania - factorul viii de coagulare - pulb.+solv. pt. sol. inj. - 500ui - vitamina k si alte hemostatice factori ai coagularii sanguine
fanhdi 1000 ui
instituto grifols s.a. - spania - factorul viii de coagulare - pulb.+solv. pt. sol. inj. - 1000ui - vitamina k si alte hemostatice factori ai coagularii sanguine
flebogamma dif 100 mg/ml
instituto grifols s.a. - spania - imunoglobulina normala pt. adm. intravasculara - sol. perf. - 100mg/ml - imunoglobuline imunoglobulina umana normala
flebogamma dif 50 mg/ml
instituto grifols s.a. - spania - imunoglobulina normala pt. adm. intravasculara - sol. perf. - 50mg/ml - imunoglobuline imunoglobulina umana normala
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - imunoglobulina umană normală - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - seruri imune și imunoglobuline, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.
tavlesse
instituto grifols s.a. - fostamatinib disodic - trombocitopenie - alte sistemice hemostatics - tavlesse este indicat pentru tratamentul infecției cronice cu trombocitopenie imună (pti) la pacienții adulți care sunt refractari la alte tratamente.